Skip to main content
Clinical Trials/IRCT20220723055530N1
IRCT20220723055530N1
Completed
Phase 2

Evaluation of the Safety and Effectiveness of Inovo Sense Smile and Inovo Sense Style Intradermal Injectable Gel for Correcting Moderate to Severe Nasolabial Folds

Khosro Medisa Teb Company0 sites30 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Khosro Medisa Teb Company
Enrollment
30
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Khosro Medisa Teb Company

Eligibility Criteria

Inclusion Criteria

  • 30 \-65 Years old men and women with moderate to severe nasolabial folds
  • Signing the informed consent form

Exclusion Criteria

  • History of a cosmetic procedure in the lower 2/3 of the face during the last three months
  • Previous allergy to Hyaluronic Acid or Lidocaine
  • Presence of inflammation, active infection, unhealed old wound, and skin lesions in the NLF region
  • People prone to hypertrophic scar formation
  • History of autoimmune or immune deficiency diseases
  • Pregnancy or breastfeeding

Outcomes

Primary Outcomes

Not specified

Similar Trials